These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 31480)
1. Neuroleptics related to butaclamol. An investigation of the effects of chlorine substituents on the aromatic rings. Humber LG; Sideridis N; Asselin AA; Bruderlein FT; Voith K J Med Chem; 1978 Dec; 21(12):1225-31. PubMed ID: 31480 [TBL] [Abstract][Full Text] [Related]
2. Neuroleptics related to butaclamol. Synthesis and some psychopharmacological effects of a series of 3-aryl analogues. Voith K; Bruderlein FT; Humber LG J Med Chem; 1978 Jul; 21(7):694-8. PubMed ID: 27637 [TBL] [Abstract][Full Text] [Related]
3. Mapping the dopamine receptor. 2. Features derived from modifications in the rings A/B region of the neuroleptic butaclamol. Philipp AH; Humber LG; Voith K J Med Chem; 1979 Jul; 22(7):768-73. PubMed ID: 571917 [TBL] [Abstract][Full Text] [Related]
4. Mapping the dopamine receptor. 1. Features derived from modifications in ring E of the neuroleptic butaclamol. Humber LG; Bruderlein FT; Philipp AH; Götz M J Med Chem; 1979 Jul; 22(7):761-7. PubMed ID: 571916 [TBL] [Abstract][Full Text] [Related]
5. Use of the butaclamol template in a search for antipsychotic agents with lessened side effects. Kukla MJ; Bloss JL; Brougham LR J Med Chem; 1979 Apr; 22(4):401-6. PubMed ID: 34721 [TBL] [Abstract][Full Text] [Related]
6. The behavioral pharmacology of butaclamol hydrochloride (AY-23,028), a new potent neuroleptic drug. Voith K; Herr F Psychopharmacologia; 1975 Apr; 42(1):11-20. PubMed ID: 1171496 [TBL] [Abstract][Full Text] [Related]
7. Effects of chlorine substituents on the benzene rings of an analogue of the antipsychotic drug butaclamol on the interaction with dopamine and muscarinic receptors in rat brain. Pugsley TA; Lippmann W J Pharm Pharmacol; 1979 Jan; 31(1):47-9. PubMed ID: 32368 [No Abstract] [Full Text] [Related]
8. Behavioral studies on the enantiomers of butaclamol demonstrating absolute optical specificity for neuroleptic activity. Voith K; Cummings JR Can J Physiol Pharmacol; 1976 Aug; 54(4):551-60. PubMed ID: 10059 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and pharmacological study of the thiophene analogue of taclamine, QM-7184, a new neuroleptic drug with potent alpha-adrenoceptor blocking activity. Arribas E; Vega S; Benito C; Fernandez-Tome MP; del Rio J Arzneimittelforschung; 1983; 33(10):1417-21. PubMed ID: 6140017 [TBL] [Abstract][Full Text] [Related]
10. Conformational properties of butaclamol and isobutaclamol. Regularities in the structures of semirigid neuroleptics. Froimowitz M; Matthysse S Mol Pharmacol; 1983 Sep; 24(2):243-50. PubMed ID: 6193405 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of 2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole derivatives and their central nervous system activities. Nagai Y; Irie A; Masuda Y; Oka M; Uno H J Med Chem; 1979 Jun; 22(6):677-83. PubMed ID: 37336 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and neuroleptic activity of benzamides. Cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide and related compounds. Iwanami S; Takashima M; Hirata Y; Hasegawa O; Usuda S J Med Chem; 1981 Oct; 24(10):1224-30. PubMed ID: 6120234 [TBL] [Abstract][Full Text] [Related]
13. 10-Piperazinyl-4H-theino[3,2-b][1,5]- and -[3,4-b][1,5]benzodiazepines as potential neuroleptics. Chakrabarti JK; Fairhurst J; Gutteridge NJ; Horsman L; Pullar IA; Smith CW; Steggles DJ; Tupper DE; Wright FC J Med Chem; 1980 Aug; 23(8):884-9. PubMed ID: 6105217 [TBL] [Abstract][Full Text] [Related]
14. Neuroleptic agents of the benzocycloheptapyridoisoquinoline series. 1. Syntheses and stereochemical and structural requirements for activity of butaclamol and related compounds. Bruderlein FT; Humber LG J Med Chem; 1975 Feb; 18(2):185-8. PubMed ID: 1168258 [TBL] [Abstract][Full Text] [Related]
15. Direct effect of neuroleptics on glutamate release. Sherman AD; Mott J Neuropharmacology; 1984 Nov; 23(11):1253-9. PubMed ID: 6084822 [TBL] [Abstract][Full Text] [Related]
16. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents. Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828 [TBL] [Abstract][Full Text] [Related]
17. The effect of the stereoisomers of butaclamol on neurotensin content in discrete regions of the rat brain. Bissette G; Dauer WT; Kilts CD; O'Connor L; Nemeroff CB Neuropsychopharmacology; 1988 Dec; 1(4):329-35. PubMed ID: 2472151 [TBL] [Abstract][Full Text] [Related]
18. 4-Piperazinyl-10H-thieno[2,3-b][1,5]benzodiazepines as potential neuroleptics. Chakrabarti JK; Horsman L; Hotten TM; Pullar IA; Tupper DE; Wright FC J Med Chem; 1980 Aug; 23(8):878-84. PubMed ID: 6105216 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological characterization of alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazinebutanol and analogues as potential atypical antipsychotic agents. Yevich JP; New JS; Lobeck WG; Dextraze P; Bernstein E; Taylor DP; Yocca FD; Eison MS; Temple DL J Med Chem; 1992 Nov; 35(24):4516-25. PubMed ID: 1361578 [TBL] [Abstract][Full Text] [Related]
20. [Effect of butaclamol enantiomers on hypothalamic tyrosine hydroxylase in the rat brain]. Mineeva MF; Raevskiĭ KS Biull Eksp Biol Med; 1984 Oct; 98(10):453-6. PubMed ID: 6208950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]